Free Trial

Baxter International (BAX) Stock Forecast & Price Target

Baxter International logo
$17.97 +0.48 (+2.73%)
Closing price 03:59 PM Eastern
Extended Trading
$17.92 -0.04 (-0.24%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Baxter International - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
3
Hold
8
Buy
2

Based on 13 Wall Street analysts who have issued ratings for Baxter International in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 13 analysts, 3 have given a sell rating, 8 have given a hold rating, and 2 have given a buy rating for BAX.

Consensus Price Target

$19.91
10.80% Upside
According to the 13 analysts' twelve-month price targets for Baxter International, the average price target is $19.91. The highest price target for BAX is $27.00, while the lowest price target for BAX is $15.00. The average price target represents a forecasted upside of 10.80% from the current price of $17.97.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for BAX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Baxter International and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BAX Analyst Ratings Over Time

TypeCurrent Forecast
5/8/25 to 5/8/26
1 Month Ago
4/8/25 to 4/8/26
3 Months Ago
2/7/25 to 2/7/26
1 Year Ago
5/8/24 to 5/8/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
5 Buy rating(s)
Hold
8 Hold rating(s)
9 Hold rating(s)
9 Hold rating(s)
4 Hold rating(s)
Sell
3 Sell rating(s)
2 Sell rating(s)
3 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$19.91$19.80$21.40$37.56
Forecasted Upside10.80% Upside14.82% Upside-1.56% Downside20.39% Upside
Consensus RatingReduceHoldReduceHold

BAX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BAX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Baxter International Stock vs. The Competition

TypeBaxter InternationalMedical CompaniesS&P 500
Consensus Rating Score
1.92
2.30
2.52
Consensus RatingReduceHoldModerate Buy
Predicted Upside10.80% Upside842.59% Upside15.51% Upside
News Sentiment Rating
Neutral News

See Recent BAX News
Neutral News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
5/1/2026
TD Cowen logo
TD Cowen
3 of 5 stars
 Lower Target$22.00 ➝ $20.00+15.91%
5/1/2026
Stifel Nicolaus logo
Stifel Nicolaus
4 of 5 stars
 Lower Target$20.00 ➝ $19.00+10.11%
5/1/2026 Boost Target$17.00 ➝ $19.00+10.11%
5/1/2026Boost TargetOverweight$25.00 ➝ $27.00+56.48%
4/24/2026 DowngradeHoldStrong Sell
4/6/2026 Lower TargetOutperform$23.00 ➝ $22.00+32.09%
3/11/2026Lower TargetNeutral$21.00 ➝ $19.00+6.24%
2/13/2026 Lower TargetHold$21.00 ➝ $19.00+1.04%
1/21/2026 Reiterated RatingSell (D)
12/12/2025Lower TargetEqual Weight$21.00 ➝ $19.00-0.29%
12/2/2025Lower TargetUnderweight$19.00 ➝ $15.00-20.83%
10/31/2025 Lower Target$25.00 ➝ $19.00+2.90%
10/31/2025Lower TargetNeutral$24.00 ➝ $21.00+11.75%
10/31/2025DowngradeBuyHold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 12:29 AM ET.


Should I Buy Baxter International Stock? BAX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, May 7, 2026. Please send any questions or comments about these Baxter International pros and cons to contact@marketbeat.com.

Baxter International
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Baxter International Inc.:

  • The current stock price is around $16.62, which is significantly lower than its 12-month high of $32.68, potentially offering a buying opportunity for investors looking for value.
  • Baxter International Inc. recently reported quarterly earnings that exceeded expectations, with earnings per share of $0.36 compared to a consensus estimate of $0.31, indicating strong operational performance.
  • The company experienced a year-over-year revenue increase of 2.9%, demonstrating resilience and growth in its medical products and therapies segment.
  • Institutional investors and hedge funds own a substantial 90.19% of the company's stock, suggesting strong confidence from large investors in Baxter International Inc.'s future prospects.
  • Baxter International Inc. has a positive return on equity of 15.65%, indicating effective management and profitability relative to shareholder equity.

Baxter International
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Baxter International Inc. for these reasons:

  • The company has a negative net margin of 9.70%, which suggests that it is currently spending more than it earns, raising concerns about profitability.
  • Baxter International Inc. has a high debt-to-equity ratio of 1.55, indicating that it relies heavily on debt financing, which could pose risks in a rising interest rate environment.
  • The P/E ratio is negative at -9.33, which can be a red flag for investors as it indicates that the company is not currently generating profits relative to its share price.
  • Despite recent revenue growth, the company has faced challenges in maintaining consistent earnings, as evidenced by a decline in earnings per share compared to the same quarter last year.
  • The stock has shown volatility, with a beta of 0.62, suggesting that it may not be as stable as some investors prefer, which could lead to unpredictable price movements.

BAX Forecast - Frequently Asked Questions

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Baxter International is $19.91, with a high forecast of $27.00 and a low forecast of $15.00.

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 3 sell ratings, 8 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" BAX shares.

According to analysts, Baxter International's stock has a predicted upside of 10.80% based on their 12-month stock forecasts.

Over the previous 90 days, Baxter International's stock had 1 upgrade and 1 downgrade by analysts.

Baxter International has been rated by research analysts at Barclays, Citigroup, Evercore, Jefferies Financial Group, Stifel Nicolaus, TD Cowen, The Goldman Sachs Group, and Zacks Research in the past 90 days.

Analysts like Baxter International less than other "medical" companies. The consensus rating for Baxter International is Reduce while the average consensus rating for "medical" companies is Hold. Learn more on how BAX compares to other companies.


This page (NYSE:BAX) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners